{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Who are in the management team of Adial Pharmaceuticals, Inc.?
As of March 2022, the management team of Adial Pharmaceuticals, Inc. includes President and CEO William Stilley, Vice Chairman Kevin Schuyler, and Independent Directors J. Kermit Anderson, Robertson Gilliland, Tony Goodman, and James Newman. They are responsible for the company's strategic direction and operations.
What does Adial Pharmaceuticals, Inc. do?
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for addictions and related disorders, with a market cap of $2.51 million and a recent net profit of -$2 million. The company operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap entity.
How big is Adial Pharmaceuticals, Inc.?
As of Jun 18, Adial Pharmaceuticals, Inc. has a market capitalization of 2.51 million, with net sales of 0.00 million and a net profit of -8.95 million over the last four quarters. The company's shareholder's funds are 4.07 million, and total assets are 5.08 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
